<DOC>
	<DOC>NCT01161745</DOC>
	<brief_summary>The investigators want to identify that whether PD-1/PD-L1 pathway will change in human sepsis, and whether PD-1/PD-L1 pathway play an important role in sepsis induced immunosuppression.</brief_summary>
	<brief_title>PD-1/PD-L1 Pathway Study on Septic Patients</brief_title>
	<detailed_description>First, we will detect PD-L1 expression on PBMC of septic patients and healthy controls. Second, blockade of PD-1/PD-L1 pathway in vitro and stimulate with some biomolecules and then analyze the PBMC function and apoptosis by flow cytometry. Then, compare with healthy controls and find the differences.</detailed_description>
	<mesh_term>Sepsis</mesh_term>
	<criteria>patients who develop sepsis patients with cirrhosis or renal dysfunction patients with dyscrasia patients with autoimmunity diseases patients with severe cardiac and pulmonary diseases patients with hematological diseases patients with diabetes mellitus patients with malignant tumors</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>sepsis</keyword>
</DOC>